Quantum-Si (NASDAQ:QSI) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Quantum-Si (NASDAQ:QSI - Free Report) in a research report released on Monday,Benzinga reports. HC Wainwright currently has a $5.50 price target on the stock. HC Wainwright also issued estimates for Quantum-Si's Q4 2025 earnings at ($0.17) EPS and FY2025 earnings at ($0.62) EPS.

Several other research firms have also recently issued reports on QSI. Alliance Global Partners reaffirmed a "buy" rating on shares of Quantum-Si in a research report on Friday, May 16th. National Bankshares set a $3.65 price objective on Quantum-Si in a research report on Wednesday, March 5th.

Quantum-Si Stock Up 11.5%

NASDAQ:QSI traded up $0.20 during trading hours on Monday, hitting $1.94. 31,505,566 shares of the company's stock traded hands, compared to its average volume of 10,482,423. The firm has a market cap of $355.29 million, a P/E ratio of -3.03 and a beta of 2.71. Quantum-Si has a 52 week low of $0.61 and a 52 week high of $5.77. The business's fifty day simple moving average is $1.30 and its two-hundred day simple moving average is $1.62.

Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.17) by $0.06. The company had revenue of $0.84 million for the quarter, compared to the consensus estimate of $0.96 million. Quantum-Si had a negative return on equity of 36.96% and a negative net margin of 3,968.84%. On average, analysts expect that Quantum-Si will post -0.65 EPS for the current year.

Insider Activity at Quantum-Si

In other news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm's stock in a transaction that occurred on Friday, March 21st. The shares were sold at an average price of $1.39, for a total transaction of $32,952.73. Following the transaction, the chief executive officer now directly owns 2,646,716 shares of the company's stock, valued at approximately $3,678,935.24. This trade represents a 0.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last quarter, insiders sold 36,650 shares of company stock valued at $50,944. Insiders own 30.04% of the company's stock.

Hedge Funds Weigh In On Quantum-Si

Several institutional investors have recently bought and sold shares of QSI. Barclays PLC increased its holdings in Quantum-Si by 210.5% during the third quarter. Barclays PLC now owns 196,826 shares of the company's stock valued at $173,000 after buying an additional 133,438 shares during the period. SG Americas Securities LLC boosted its stake in Quantum-Si by 12.4% in the fourth quarter. SG Americas Securities LLC now owns 67,588 shares of the company's stock valued at $182,000 after acquiring an additional 7,470 shares in the last quarter. Abel Hall LLC acquired a new stake in Quantum-Si in the fourth quarter valued at approximately $28,000. Rhumbline Advisers boosted its stake in Quantum-Si by 3.7% in the fourth quarter. Rhumbline Advisers now owns 148,946 shares of the company's stock valued at $402,000 after acquiring an additional 5,298 shares in the last quarter. Finally, Sanctuary Advisors LLC acquired a new stake in Quantum-Si in the fourth quarter valued at approximately $95,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.